CONSTRUCTION AND CHARACTERIZATION OF A VI-POSITIVE VARIANT OF THE SALMONELLA-TYPHI LIVE ORAL VACCINE STRAIN TY21A

被引:17
作者
CRYZ, SJ [1 ]
FURER, E [1 ]
BARON, LS [1 ]
NOON, KF [1 ]
RUBIN, FA [1 ]
KOPECKO, DJ [1 ]
机构
[1] WALTER REED ARMY MED CTR, WASHINGTON, DC 20307 USA
关键词
D O I
10.1128/IAI.57.12.3863-3868.1989
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:3863 / 3868
页数:6
相关论文
共 33 条
[1]   PREVENTION OF TYPHOID-FEVER IN NEPAL WITH THE VI CAPSULAR POLYSACCHARIDE OF SALMONELLA-TYPHI - A PRELIMINARY-REPORT [J].
ACHARYA, IL ;
LOWE, CU ;
THAPA, R ;
GURUBACHARYA, VL ;
SHRESTHA, MB ;
CADOZ, M ;
SCHULZ, D ;
ARMAND, J ;
BRYLA, DA ;
TROLLFORS, B ;
CRAMTON, T ;
SCHNEERSON, R ;
ROBBINS, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (18) :1101-1104
[2]  
BARON LS, 1982, GENETIC ENG MICROORG, P175
[3]  
BLACK R, 1982, DEV BIOLOGICALS, V53, P9
[4]   DEMONSTRATION OF SPECIFIC IGA IN HUMAN FECES AFTER IMMUNIZATION WITH LIVE TY21A SALMONELLA-TYPHI VACCINE [J].
CANCELLIERI, V ;
FARA, GM .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) :482-484
[5]  
CRYZ SJ, 1988, SCHWEIZ MED WSCHR, V118, P467
[6]   FURTHER CHARACTERIZATION OF THE SALMONELLA-TYPHI TY21A VACCINE STRAIN [J].
CRYZ, SJ ;
FURER, E .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (06) :1276-1277
[7]   COMPARATIVE-ANALYSIS OF IMMUNOLOGICAL RESPONSES TO ORAL (TY21A) AND PARENTERAL (TAB) TYPHOID VACCINES [J].
DAMELIO, R ;
TAGLIABUE, A ;
NENCIONI, L ;
DIADDARIO, A ;
VILLA, L ;
MANGANARO, M ;
BORASCHI, D ;
LEMOLI, S ;
NISINI, R ;
MATRICARDI, PM .
INFECTION AND IMMUNITY, 1988, 56 (10) :2731-2735
[8]  
EDELMAN R, 1986, REV INFECT DIS, V8, P329
[9]   ISOLATION AND CHARACTERIZATION OF GAL-E MUTANT TY 21A OF SALMONELLA-TYPHI - CANDIDATE STRAIN FOR A LIVE, ORAL TYPHOID VACCINE [J].
GERMANIER, R ;
FURER, E .
JOURNAL OF INFECTIOUS DISEASES, 1975, 131 (05) :553-558
[10]   IMMUNITY IN EXPERIMENTAL SALMONELLOSIS .2. BASIS FOR AVIRULENCE AND PROTECTIVE CAPACITY OF GAL-E MUTANTS OF SALMONELLA-TYPHIMURIUM [J].
GERMANIER, R ;
FURER, E .
INFECTION AND IMMUNITY, 1971, 4 (06) :663-+